Active Trading

Tim Begany
Tim Begany
December 16, 2014

A 'Forgotten' Dividend Aristocrat That Combines Income And Growth

This little-known firm has increased its payout for more than four decades straight. Here's why it's capable of delivering many more dividend raises and impressive capital gains in coming years.

Andy Obermueller
Andy Obermueller
February 27, 2015

A Surprising Way To Profit From McDonald's Biggest Problem

Beef prices have been on a tear recently, and McDonald's has been feeling the pain. So the question is, who benefits from the fast-food industry woes? This company does.

 

David Sterman
David Sterman
February 27, 2015

Avoid Amazon -- Before It Disappoints You, Again

The company's stock price rebound has been both remarkable and inexplicable. Here's why the company is overvalued and should be avoided.

Joseph Hogue
Joseph Hogue
February 26, 2015

The $7 Billion Reason To Short Retail

West coast ports are open again, but delayed freight has huge implications for the retail sector. Details here.

David Sterman
David Sterman
February 25, 2015

3 Small Companies Targeted By Legendary Gurus

Our generations top hedge fund managers generally focus on larger companies, but when they start to load up on shares of small-caps, you should follow suit. Find out which ones they're buying here.

Dave Forest
Dave Forest
February 25, 2015

The 4 Key Traits Of A World-Class Stock

Beating the market really just comes down to having discipline. Let me show you what I mean...

Joseph Hogue
Joseph Hogue
February 24, 2015

Stagflation Is Coming -- Prepare Now

We haven't experienced stagflation since the 70s, but signs point to the possibility of its return. Here's how to position your portfolio.


John Kosar
February 23, 2015

In The Week Ahead: 2 Reasons The Market Could Move Higher

Across-the-board strength in equities is being led by tech and small caps, signaling a healthy advance that is likely to continue.

David Sterman
David Sterman
February 23, 2015

Warning: Before Investing In This Bankruptcy-Ridden Industry, Read This

As the weakest firms file for bankruptcy and the strongest players make acquisitions, there are strong long and short plays for this struggling industry. Details here.

David Sterman
David Sterman
February 20, 2015

This $110 Billion Pharma Revolution Could Make Or Break Your Portfolio

The dynamics of the pharmaceutical industry could soon change and winners and losers are lining up on both sides. Here’s how to prepare your portfolio.